Related Experiment Video
Updated: May 27, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Management of diabetes in pregnancy
Jerasimos Ballas1, Thomas R Moore, Gladys A Ramos
1Reproductive Medicine Department, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USA.
Insights
Diabetes in pregnancy significantly impacts maternal and fetal health, leading to complications like congenital anomalies and stillbirth. New screening guidelines aim to mitigate these risks associated with hyperglycemia during gestation.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Neonatal Medicine
Background:
- The association between diabetes and adverse pregnancy outcomes is extensively documented.
- Diabetes in pregnant individuals affects multiple maternal organ systems.
- In utero exposure to diabetes can cause fetal anomalies, overgrowth, stillbirth, and metabolic issues extending into later life.
Purpose of the Study:
- To highlight the latest guidelines for screening diabetes in pregnancy.
- To review the impact of these guidelines on maternal and neonatal complications.
- To address hyperglycemia in pregnancy and its associated risks.
Main Methods:
- Review of current literature on diabetes screening in pregnancy.
- Analysis of recent guideline updates.
- Examination of maternal and neonatal outcomes related to gestational hyperglycemia.
Main Results:
- Updated screening guidelines offer a framework for early detection of diabetes in pregnancy.
- Implementation of new guidelines may influence the incidence of maternal and neonatal complications.
- Understanding the long-term metabolic effects on offspring exposed to maternal diabetes is crucial.
Conclusions:
- Adherence to updated screening protocols is vital for managing diabetes in pregnancy.
- Early identification and management of hyperglycemia can potentially reduce adverse maternal and fetal outcomes.
- Further research is needed to fully elucidate the long-term impact of in utero diabetic exposure on offspring health.
Abstract:
The link between diabetes and poor pregnancy outcomes is well established. As in the non-pregnant population, pregnant women with diabetes can experience profound effects on multiple maternal organ systems. In the fetus, morbidities arising from exposure to diabetes in utero include not only increased congenital anomalies, fetal overgrowth, and stillbirth, but metabolic abnormalities that appear to carry on into early life, adolescence, and beyond. This article emphasizes the newest guidelines for diabetes screening in pregnancy while reviewing their potential impact on maternal and neonatal complications that arise in the setting of hyperglycemia in pregnancy.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction
Diabetes: Symptoms, Diagnosis, and Complications

